Skip to content
Search

Latest Stories

Dhamecha Group acquires east London depot from TRS

Dhamecha Group acquires east London depot from TRS

By Jaimin Solanki

ONE of UK's largest independent wholesaler Dhamecha Cash & Carry has acquired a depot in East London from rival TRS.


The site in Leyton will be Dhamecha’s tenth unit in the country which currently operates seven sites in London and branches in Birmingham and Leicester.

According to reports, the completion of the deal is expected to take place by the end of February.

Dhamecha Group bought the site from private equity firm Exponent, which acquired TRS and East End Foods in 2019. Exponent created a

new business called Vibrant Foods to bring the TRS and East End businesses together.

Pradip Dhamecha, chief executive of the group has said that the deal included provision to sell a selection of TRS and East End-branded products.

He added that it is planning to fully refurbish the site over several months before opening.

“We have been in discussions with TRS and their owners, Vibrant Foods, for a period of time and are excited to make this addition to our group. The depot will close for several months for renovation and refurbishment. We look forward to welcoming both new and existing customers when the depot re-opens later in 2021," said Dhamecha.

“As part of the acquisition of the new depot, we are also delighted that we will be able to provide a good selection of TRS and East End branded products in our depots. As we expand our footprint we will continue to build on our reputation for excellent service, competitive pricing and great stock availability. We look forward to working closely with all our customers, suppliers and our loyal colleagues.”

Dhamecha Cash & Carry was established in 1976 by three brothers KR, SR and JR Dhamecha, when they opened their first unit in Wembley.

Currently, it has around 14,000 trade-only customers and offers a range of more than 12,000 branded products.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less